These observations indicated that the KT11 treatment accelerated the liver tumor progression in the kras zebrafish, but had no effects on kras/L-ARKO zebrafish, suggesting the liver-specific ar knockout blocked the effects of KT11 during liver tumor progression. This evidence concerns the gene KRAS and Neoplasm of the liver.